Printer Friendly
The Free Library
19,607,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Dendrite International, Inc. Announces Stock Repurchase Program.


Business Editors

MORRISTOWN, N.J.--(BUSINESS WIRE)--Jan. 31, 2001

Dendrite dendrite: see nervous system; synapse.  International, Inc., the leading provider of sales and marketing effectiveness Marketing Effectiveness is the function of improving how marketers go to market with the goal of optimizing their marketing spend to achieve even better results for both the short-term and long-term. Also related to Marketing ROI and Return on Marketing Investment (ROMI).  solutions for the pharmaceutical industry (NASDAQ/NMS: DRTE DRTE Defence Research Telecommunications Establishment ), announced today that its Board of Directors has authorized a stock repurchase Stock repurchase

A firm's repurchase of outstanding shares of its common stock.
 program (the "Repurchase Program").

The Board of Directors authorized the repurchase of up to $20 million of its outstanding common stock over a two-year period.

[pilcrow (paragraph sign)] The Company will repurchase shares on the open market or in privately negotiated transactions from time to time. Repurchases of stock will be at management's discretion, depending upon price and availability. The repurchased shares will be held as treasury shares, which may be used to satisfy Dendrite's current and near term requirements under its equity incentive and other benefit plans and for other corporate purposes. Dendrite currently has approximately 40 million shares of common stock outstanding.

John Bailye Chairman and Chief Executive Officer of Dendrite International, Inc. commented, "We believe that our stock presents a very attractive investment opportunity for the Company at this time. The implementation of the Repurchase Program serves to underscore The underscore character (_) is often used to make file, field and variable names more readable when blank spaces are not allowed. For example, NOVEL_1A.DOC, FIRST_NAME and Start_Routine.

(character) underscore - _, ASCII 95.
 our strong commitment to enhance shareholder value."

ABOUT DENDRITE

Dendrite International, Inc. (NASDAQ/NMS:DRTE) designs and supports technology-based knowledge systems that enhance the competitive activities of the sales forces of the world's leading pharmaceutical companies. Approximately one-third of all pharmaceutical sales representatives pharmaceutical sales representative Detailer, Drug rep Drug industry A drug company employee who regularly visits physicians and office practices, providing information on the company's products–usually putting a negative 'spin' on competitors' products. See Detailing.  and their managers worldwide rely on Dendrite.

www.dendrite.com

Note: Dendrite is a registered trademark of Dendrite International, Inc.

The foregoing contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. The statements may be identified by such forward-looking terminology as "expect," "believe," "may," "will," "intend," "plan" and similar statements or variations. Such forward-looking statements are based on our current estimates and assumptions and involve certain significant risks and uncertainties, including: risks associated with and dependence on the pharmaceutical industry; fluctuations in quarterly revenues due to lengthy selling cycles, product implementation cycles, customer budget cycles, and timing of revenue recognition; dependence on major customers; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; retention of key senior managers; and unique characteristics of the consumer packaged goods Noun 1. packaged goods - groceries that are packaged for sale
foodstuff, grocery - (usually plural) consumer goods sold by a grocer

plural, plural form - the form of a word that is used to denote more than one
 industry. Other important factors, which should be considered, are included in the Company's 10-K, 10-Qs and other reports filed with the SEC. Actual results may differ materially. The Company assumes no obligation for updating any such forward-looking statements.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 31, 2001
Words:403
Previous Article:Super Bowl Drives Major Traffic Surge to CBS and Its Partner Web Sites, Reports Jupiter Media Metrix.
Next Article:Allergan Reports Fourth Quarter and Year-End Operating Results.
Topics:



Related Articles
Dendrite Reports Record Results; First Quarter 1999 Revenue Up 43%; EPS Up 114 % To $0.15 Per Share Diluted.
Dendrite Withdraws Follow-on Offering Due to Unfavorable Market Conditions.
Dendrite Releases Historical Supplemental Financial Information to Reflect Pooling Acquisition of CorNet.
Dendrite Announces Three-For-Two Stock Split.
Dendrite Holds Analysts and Investor Meeting; Details New Products & Services; Updates Financial Model; Raises Estimates; Announces 3-for-2 Split.
Dendrite Announces Acquisition of MMI as Next Step in Global Reach Strategy.
Dendrite International Board Mandates New Executive Share Ownership Policy; Program Reflects Positive Expectations.
Dendrite International, Inc. Announces Shareholder Rights Plan.
Dendrite Reports First Quarter Results; First Quarter 2001 Revenue $51.9 million Net Income $1.5 million, EPS $.04 per share.
Dendrite Resumes Stock Repurchase Program.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles